XML 32 R19.htm IDEA: XBRL DOCUMENT

WARRANTS

3 Months Ended

Mar. 31, 2026

NOTE 11 – WARRANTS

In connection with a note (see Note 9 – Debt), in August 2024 the Company issued 76,923 warrants to purchase common stock. The warrants have an exercise price of $9.36 per share, are immediately exercisable and have a term of 5 years. In August 2024, the holder exercised 28,571 warrants for shares of common stock on a cashless basis. Pursuant to the adjustment provisions in Section 3(b) of the warrant agreement, the exercise price automatically adjusted following the Company’s issuance of shares at a dilutive price of $1.20 on or about August 14, 2025, resulting in an automatic increase in the aggregate warrant share amount. Accordingly, in August 2025, the holder exercised aggregate of 279,402 warrants for shares of common stock on a cashless basis, including 12,706 warrants issued on October 4, 2023.

Warrant liability

As of March 31, 2026, the Company remeasured the fair value of warrants outstanding at $0. In connection with the remeasurement of warrants, a gain of $10,910 was recognized during the three months ended March 31, 2026, as the change in fair value of warrant liability.

The Company classifies its outstanding warrant liability within Level 3 of the fair value hierarchy, as the fair value is determined using the Black-Scholes option-pricing model with unobservable inputs. The following assumptions were used to estimate the fair value of the warrant liability as of March 31, 2026:

	Three Months Ended
	March 31,
	2026
Expected stock price	$	0.29
Exercise price	$	22.50
Remaining contractual term (years)		1.52
Expected volatility		88.79	%
Risk-free interest rate		4.70	%
Expected dividend yield		0.00	%

Changes in the fair value of the warrant liability, which is measured on a recurring basis using Level 3 inputs, for the three months ended March 31, 2026, were as follows:

SCHEDULE OF CHANGE IN WARRANT LIABILITY

	Warrant
	Liability
Outstanding as of December 31, 2025	$	10,914
Change in fair value		(10,910	)
Rounding off		(4	)
Outstanding as of March 31, 2026	$	-

The Company’s outstanding and exercisable warrants, as of March 31, 2026, are presented below:

	Number Outstanding		Weighted Average Exercise Price		Contractual Life In Years		Intrinsic Value
Warrants outstanding as of December 31, 2025		177,536	$	22.50		1.76	$	-
Warrants granted		-		-		-		-
Warrants forfeited, expired, cancelled		-		-		-		-
Warrants exercised		-		-		-		-
Warrants outstanding as of March 31, 2026		177,536	$	22.50		1.52		-
Warrants exercisable as of March 31, 2026		177,536	$	22.50		1.52		-